National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,

Slides:



Advertisements
Similar presentations
Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital.
Advertisements

M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.
REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.
Alcohol screening and brief intervention delivery to an Irish cohort of opiate dependent methadone maintained patients. Catherine Darker (PhD) Department.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
An investigation of substance use patterns and associated issues in urban treatment-seeking Northern Plains American Indians Native Research Network 2011.
ARQ part II data management Training pack 1: Content and conceptual issues.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Spring 2011 Molly Bell, Colleen Dell, and Randy Duncan Emerging Trends in Alcohol and Drug Use in Saskatoon: Highlights.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Quality Management Update March 18, New Performance Improvement Project (1) Title: Controlled Substance Prescription Monitoring Program Database.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Impact of Online Counseling Farrokh Alemi, Ph.D..
1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
SOHO RAPID ACCESS CLINIC. AIMS: n To provide a client focussed, low threshold flexible prescribing service. n To offer an easily accessible assessment.
Knowledge for welfare and health National Research and Development Centre for Welfare and Health 1 Integration of social and health care services Lessons.
Erik Iversen, Norway Workshop at the annual TDI expert meeting EMCDDA, Lisbon 25 September 2006 Data Coverage Assessment The Bergen Clinics Foundation,
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
STRATEGY OF DRUG AND HIV/AIDS PREVENTION IN THE CITY AND DISTRICTS OF TALLINN Ene Tomberg Department of Social Welfare and Health Care of Tallinn.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Finnish prison suicides from 1st January 2001 to 31st December 2010.
Lifetime prevalence of Tobacco use, per age cohort in the United States (1997) and the Netherlands (1997) Source: Office of Applied Studies, SAMSHSA, National.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
„ Roma and Drugs in Figures – the Czech Republic“ Budapest, October 2004 Czech National Focal Point for Drugs and Drug Addiction Office of the Government.
Gerhard Bühringer, Monika Sassen Institut für Klinische Psychologie und Psychotherapie Institut für Therapieforschung, München EMCDDA work and scientific.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Introduction Results and Conclusions On counselor background variables, no differences were found between the MH and SA COSPD specialists on race/ethnicity,
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Using the new treatment prevalence protocol in Ireland Suzi Lyons.
Hungarian data on treated drug users, 2003 József Rácz Source: Hungarian National Drug Focus Point.
Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine.
#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.
Jennifer R. Havens, PhD, MPH Associate Professor
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Maldives.
Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.
HIV and AIDS Data Hub for Asia-Pacific 1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
Piloting Disability Disaggregation in Routine Data Collection - A pilot in eye health.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
Knowledge for welfare and health National Research and Development Centre for Welfare and Health International Development Collaboration1 Social inclusion.
Client characteristics and treatment needs (CARED-Project)*
10th Annual Susan Li Conference
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Marie P. Bresnahan, MPH, Mary M
WHO minimum public health data set on prison health
European Questionnaire on Drug Use among Prisoners - EQDP
Reitox National Focal Point National Bureau for Drug Prevention
Continuous treatment in Finland
Linda Montanari Programme P1: Monitoring the Situation
THL protects and promotes health and welfare in Finland
Center for Behavioral Health Statistics and Quality
Presentation transcript:

National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari, Stakes

National Research and Development Centre for Welfare and Health Knowledge for welfare and health2 STAKES Information Division The division maintains national statistics and registers, and functions as a centre of excellence for information and communication technology in the field of social welfare and healthcare. An official status as a statistical authority. Our main clients are national and international decision-makers and actors.

National Research and Development Centre for Welfare and Health Knowledge for welfare and health3 Groups at STAKES Information Health Statistics and Indicators Alcohol and Drug Statistics and Reproduction Statistics Social Care and Personnel Statistics STAKES Unit for eHealth and eWelfare Statistical Information Systems

National Research and Development Centre for Welfare and Health Knowledge for welfare and health4 Contents of the presentation Background of Drug Treatment Information System Principles of data collection Description of data 2006 Results Future challenges

National Research and Development Centre for Welfare and Health Knowledge for welfare and health5 Background of the Drug Treatment Information System (1/2) Managed by Ms. Kristiina Kuussaari at Stakes, within the Finnish Focal Point of Reitox network Based on the EMCDDA protocol (Treatment Demand Indicator) Data collection was piloted in Finland in 1996 Round-the-year data collection since 2000

National Research and Development Centre for Welfare and Health Knowledge for welfare and health6 Background of the information system (2/2) Voluntary for the participating units Anonymous (national identity number, name or place of domicile are not requested). Overlapping case identification code is used. The data is reported annually both nationally and internationally (EMCDDA, UN)

National Research and Development Centre for Welfare and Health Knowledge for welfare and health7 Data collection process Data is collected either on paper questionnaires or electronically At the moment about 60 percent of the data is received electronically Training on data collection and use of electronic tool is provided for the staff of participating units twice per year Client data is collected when the client is in the specific treatment for the first time that year (incl. clients who continue treatment from the previous year on 1st of January) Data is based on self-reporting

National Research and Development Centre for Welfare and Health Knowledge for welfare and health8

National Research and Development Centre for Welfare and Health Knowledge for welfare and health9 Data collected on every client: Type of current treatment, history in treatment, route of referral to treatment, medication used in treatment Sociodemografic background History of substance abuse (drugs, route of administration, age of first use etc.) Risk behaviour (injecting, sharing of needles, testing and test results of infectious diseases) Additional national part on Subsitution Treatment

National Research and Development Centre for Welfare and Health Knowledge for welfare and health Data 133 units submitted data (no full coverage) Data on 5730 clients Analysis consists of data on 4865 clients (after cleansing of the overlapping cases)

National Research and Development Centre for Welfare and Health Knowledge for welfare and health11 Where is the data coming from? Most of the data (39 % in 2006) originates from general outpatient services for substance abusers (A-Clinics, youth clinics etc.) One fourth of the data is from inpatient units for substance users and another fourth from outpatient services scecialised in drug abuse Some data from health councelling centres (NSPs) and substance abuse treatment units in prisons.

National Research and Development Centre for Welfare and Health Knowledge for welfare and health Sociodemographic background and substance abuse history All clients (N=570) First time in treatment of all clients (N=990) All clients (N=5499) First time in treatment of all clients (N=884) All clients (N=4865 ) First time in treatment of all clients (N=655) Males (%) Mean age (yrs) 27,323,627,624,22825 Proportion of clients first time in treatment (%) Singles (%) Comprehensive school only (%) (compulsory education) Unemployed (%) Homeless (%) Mean age by the time of starting using alcohol (yrs) 12,71312,813,312,813,4 Mean age by the time of starting drug use (yrs) 15,816,415,61615,615,8 Injecting drug use, lifetime prevalence (%) Injecting drug use, last month prevalence (%) Mean age by the time of starting injecting (yrs) 19,119,61919,718,919,6

National Research and Development Centre for Welfare and Health Knowledge for welfare and health13 Age groups of clients in 2006 (%)

National Research and Development Centre for Welfare and Health Knowledge for welfare and health14 Drug group 1st drug2nd drug3rd drug4th drug5th drug Subgroup(N=4865) Opioids Heroin Buprenorphine Other opioids Stimulants Amfetamines Ecstasy Cocaine Other stimulants Hypnotics and sedatives Benzodiapines Other sedatives Hallucinogens Volatile inhalants Cannabis Alcohol + drug (polydrug use) Other drug No information All100

National Research and Development Centre for Welfare and Health Knowledge for welfare and health15 Primary drug among clients,

National Research and Development Centre for Welfare and Health Knowledge for welfare and health16 Polydrug use in 2006 (%) Primary drugSecondary and tertiary drug used along with the primary drug (%) Clients%OpioidsStimulantsCannabis Hypnotics and sedatives Alcohol Opioids heroin buprenorphine Stimulants Cannabis Pharmaceuticals Alcohol <1

National Research and Development Centre for Welfare and Health Knowledge for welfare and health17 Injecting behaviour by primary drug

National Research and Development Centre for Welfare and Health Knowledge for welfare and health18 Testing and test results of hepatitis C according to years of drug abuse in 2006 (%)

National Research and Development Centre for Welfare and Health Knowledge for welfare and health19 Future challenges 1.Improve the data quality -> broader and more systematic data cleansing with the help of software application 2.Improve the coverage 3.Increase the proportion of units submitting data electronically